The Effect of Post-Scenario Debriefing and Rapid Cycle Deliberate Practice in Anaphylactic Shock Training on Nursing Students' Knowledge, Performance, Self-Confidence, and Satisfaction

February 6, 2026 updated by: BETUL SAHIN KILINC, Baskent University
This study aims to examine the effect of rapid cycle deliberate practice (RCDP) on nursing students' knowledge, performance, self-confidence, and satisfaction levels regarding anaphylactic shock management. Based on a randomized controlled study design, the study will compare third-year nursing students in terms of RCDP application with traditional analysis methods performed at the end of a scenario. Students, divided into intervention and control groups, will have their knowledge levels, simulation performance, self-confidence, and satisfaction assessed using various scales. The retention of learning and students' subjective learning experiences will also be included in the research. The outcome of this study will determine whether RCDP is an effective method for improving critical clinical decision-making and emergency management skills in nursing students.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ankara
      • Ankara, Ankara, Turkey (Türkiye), 06790
        • Baskent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • To agree to participate in the study:
  • Being a 3rd year nursing student
  • Not working as a nurse in a hospital or any healthcare facility

Exclusion Criteria:

  • • Refusing to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
rapid cycle deliberate practice
Unlike traditional debriefing, feedback is provided by pausing the scenario within the simulation. Then the part of the script up to the pause point is repeated.
Experimental: Control group
post-scenario debriefing
Debriefing is performed at the end of the simulation scenario.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nursing students' knowledge level regarding shock and anaphylactic shock: Knowledge Test Regarding Nursing Management in Anaphylactic Shock
Time Frame: before the intervention, on the day of the intervention, and 8 weeks after the intervention.
Knowledge Test Regarding Nursing Management in Anaphylactic Shock The 'Knowledge Test Regarding Nursing Management in Anaphylactic Shock,' developed by researchers in line with the literature (Ren et al., 2022; Arslan, 2021; Wang et al., 2021; Karadakovan & Eti Aslan, 2017; Eti Aslan, 2017; Nair & Peate, 2018), will be administered as follows: a 'Pre-Test' before the training to determine the students' current knowledge level regarding shock and anaphylactic shock; a 'Post-Test' immediately following the simulation application after the training; and a '1st Retention Test' 8 weeks later to measure the retention of learning. The Knowledge Test consists of 25 multiple-choice questions with 5 options each, focusing on knowledge levels regarding shock and anaphylactic shock. This form has been finalized with necessary adjustments based on expert opinions. The maximum score on this test is 100 points, and the minimum is 0 points. A higher score indicates a higher level of knowledge.
before the intervention, on the day of the intervention, and 8 weeks after the intervention.
Simulation Performance Checklist: Nursing Students' Performance Level Regarding Anaphylactic Shock
Time Frame: on the same day as the intervention and 8 weeks after the intervention
Simulation Performance Checklist The 'Simulation Performance Checklist for Nursing Management in Anaphylactic Shock', created by researchers in line with the literature (Casale et al., 2023; Ren et al., 2022; Arslan, 2021; Dreborg and Him, 2021; Wang et al., 2021; Eti Aslan, 2017; Karadakovan, 2017), will be used to determine students' performance levels. A 'Post-Test' will be administered immediately after the simulation application, and a '1st Retention Test' will be administered after 8 weeks to measure the retention of learning. The checklist consists of 10 items, and each item is scored as "0 = Could not/Did not apply/No", "1 = Did/Applied/Yes". A minimum score of 0 and a maximum score of 10 can be obtained from the checklist. This form has been finalized after necessary adjustments were made in line with expert opinions.
on the same day as the intervention and 8 weeks after the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Student Satisfaction and Self-Confidence in Learning Scale: Self-confidence and satisfaction levels of nursing students
Time Frame: before the intervention and on the day of the intervention
Student Satisfaction and Self-Confidence in Learning Scale The Student Satisfaction and Self-Confidence in Learning Scale was developed by Jeffries and Rizzolo (2006), and the Turkish adaptation, validity, and reliability study were conducted by Ünver et al. (2017). The scale consists of 12 items and has two sub-dimensions: student satisfaction (5 items) and self-confidence in learning (7 items). The scale is administered using a 5-point Likert scale (1=Strongly disagree - 5=Strongly agree). In the Turkish version, the Cronbach alpha coefficient was found to be between 0.77 and 0.85, showing that it is a valid and reliable measurement tool. A minimum score of 12 and a maximum score of 60 can be obtained from this scale. A score closer to 60 indicates positive results.
before the intervention and on the day of the intervention
Debriefing Experience Scale
Time Frame: The simulation applications will be conducted on the same day.
In this study, the Debriefing Experience Scale, developed by Reed (2012) and adapted into Turkish by Uslu et al. (2022), will be used as a data collection tool. The scale consists of 20 items and four sub-dimensions, and is a 5-point Likert type scale. The Cronbach's alpha coefficients of the Turkish form of the scale were determined as 0.948 for "Evaluation Experience" and 0.951 for "Importance of Item"; the test-retest reliability was ICC=0.999 (p<0.001). It was stated that the Turkish version is valid and reliable. A minimum score of 20 and a maximum score of 100 can be obtained from this scale. A score closer to 100 indicates positive results.
The simulation applications will be conducted on the same day.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

July 15, 2026

Study Registration Dates

First Submitted

January 21, 2026

First Submitted That Met QC Criteria

January 31, 2026

First Posted (Actual)

February 5, 2026

Study Record Updates

Last Update Posted (Actual)

February 10, 2026

Last Update Submitted That Met QC Criteria

February 6, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 171622998.600-294

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nursing Education

Clinical Trials on rapid cycle deliberate practice

Subscribe